A company that’s developing a smart-pill drug delivery and monitoring system is the latest tenant to join Catalyst HTI in RiNo.
Veloce Corp. joins a community that will include national healthcare organizations like Kaiser Permanente, Anschutz Medical Campus and American Osteopathic Association, as well as health-tech startups like CirrusMD, BurstIQ and Telespine.
“We’re thrilled to be joining the Catalyst HTI community,” says Robert Niichel, CEO of Veloce. “Moving our offices to the building should help us acquire funding, forge partnerships and meet clients. It will also enable healthcare providers to learn about our SmartTab drug delivery and monitoring system.”
SmartTab will deliver active ingredients to specific areas of the human body at specific times or in response to a monitored physiological condition. The system will interface with custom or current wearable monitoring technology. It has the capability to deliver a wide range of active ingredients and interact with the Internet of Medical Things to optimize patient care.
“Our SmartTab platform achieves a level of precision in drug delivery that was previously impossible,” Niichel says. “With SmartTabs, providers can monitor the efficacy of treatment regimens and ensure medical compliance, which can be a costly and often deadly problem.”
After being spun out of Nano Pharmaceutical Laboratories in 2015, Veloce was accepted into StartUp Health’s investment portfolio, which contains nearly 200 health-tech startups. Veloce received a patent for its drug delivery and monitoring system earlier this year.